Gregory Naeve will become Bellicum Pharmaceuticals Inc.'s chief business officer Aug. 21.
Naeve was previously immuno-oncology and cell therapy lead for Pfizer Inc.'s external research and development unit.
Bellicum Pharmaceuticals appoints chief business officer
Banking Essentials Newsletter - February Edition
Message in a (Word)Cloud
Six trends shaping the industries and sectors we cover in 2021
Six trends shaping the industries and sectors we cover in 2021
Bellicum Pharmaceuticals appoints chief business officer
- Author Ephraim Bie
- Theme Healthcare & Pharmaceuticals
- Author
- Ephraim Bie
- Theme
- Healthcare & Pharmaceuticals